Accelerating COVID-19 testing: An experimental approach.

Area of Science:

• Public Health
• Epidemiology
• Biotechnology

Background:

• The COVID-19 pandemic necessitated widespread testing, straining global test kit supplies.
• Lockdowns and social distancing measures were implemented to curb viral spread, increasing demand for diagnostic tools.
• Limited test kit availability hindered effective mass testing strategies worldwide.

Purpose of the Study:

• To propose a novel approach, Encoded Blending (EB), to dramatically increase COVID-19 testing volume.
• To address the challenge of limited test kit supply during the pandemic.
• To optimize pooled testing strategies for efficient mass screening.

Main Methods:

• The study introduces Encoded Blending (EB), a modification of the existing pooled testing method.
• EB aims to maximize the number of individuals tested using a fixed number of test kits.
• This approach builds upon pooled testing strategies successfully employed by countries like Germany, Israel, and South Korea.

Main Results:

• Encoded Blending (EB) demonstrated the potential to significantly increase testing capacity without additional test kits.
• The method showed a potential reduction in test kit requirements by up to 85% in populations with 5% prevalence.
• A reduction of up to 80% in test kit usage was observed in populations with 10% prevalence.

Conclusions:

• Encoded Blending (EB) offers a viable solution to overcome test kit limitations during pandemics.
• The proposed method can substantially enhance the efficiency and scalability of mass COVID-19 testing.
• EB represents a significant advancement in diagnostic strategies for infectious disease outbreaks.